Agreement extends current cash runway to Q1 2023 Agreement extends current cash runway to Q1 2023

View post:
VBL Therapeutics Enters Into Ordinary Share Purchase Agreement of up to $20 Million With Aspire Capital Fund, LLC

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh